The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
Controversial columnist Katie Hopkins will not face charges over a Twitter outburst that described Scottish people as "little sweaty jocks".
Tens of thousands of fans of Arsenal and Aston Villa have descended on Wembley Stadium today for the FA Cup Final.
We round up the best reaction on social media to the news that Rio Ferdinand is hanging up his boots